Orca Capital AG 13D/13G Filings for Silexion Therapeutics Ltd. (SLXN)

Orca Capital AG 13D and 13G filings for Silexion Therapeutics Ltd.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-09-15
5:23 pm
Sale
2025-09-1113GSILEXION THERAPEUTICS CORP
SLXN
Orca Capital AG10,943
4.900%
-2,182decrease
(-16.62%)
Filing
2025-09-15
5:19 pm
Purchase
2025-09-1113GSILEXION THERAPEUTICS CORP
SLXN
Orca Capital AG13,125
6.200%
13,125increase
(New Position)
Filing